ICAM1 and cancer: Two clear-cut observations were made: CD54 expression was significantly increased by ≥ 35.6% (p < 0.001) and HLA-DR expression was decreased by ≥ 10.8% (p < 0.001) in all the cancer subgroups and women operated for benign conditions as compared to healthy blood donors.